News Releases

Month Year

Month Year

Mar 4, 2022

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Mar 3, 2022

Insmed To Present at the Cowen 42nd Annual Health Care Conference
Feb 17, 2022

Insmed Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business and Pipeline Update

--ARIKAYCE® (amikacin liposome inhalation suspension) Total Revenue of $56.1 Million for the Fourth Quarter and $188.5 Million for the Full Year 2021; Anticipate at Least 30% Year Over Year Annual Growth for 2022--
Feb 10, 2022

Insmed To Present at the SVB Leerink Virtual 11th Annual Global Healthcare Conference
Feb 4, 2022

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jan 27, 2022

Insmed to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Provide a Business and Pipeline Update on Thursday, February 17, 2022
Jan 4, 2022

Insmed To Present at the 40th Annual J.P. Morgan Healthcare Conference
Dec 6, 2021

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Nov 5, 2021

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Nov 3, 2021

Insmed To Participate in Three November Conferences

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

View the latest Insmed Investor Presentation